Munayer CJE, Maza JG, Carpio HJC, Aldana PT, Lázaro CJL, Luis MR, Ramírez RH, Amaya HA, Pineda OJL

Language: Spanish
References: 13
Page: 306-309
PDF size: 46.58 Kb.

ABSTRACT

Objective: We present two cases of Patent Foramen Ovale (PFO) treated with percutaneous Amplatzer device. Method: The first case corresponds to 48 years old woman with Ebstein’s disease with moderate to severe hemodynamic repercussion and three cerebrovascular accidents, the last one under coumarin treatment, she received antiarrhythmic medication and despite of it developed 1st degree AV block, supra-ventricular and ventricular ectopia, rigth branch block. The second case corresponds to a 22 years old man with antecedents of cerebrovascular accident at the age of 21 with sequelae of convulsive crisis. Both patients were percutaneously treated with Amplatzer devices. The first patient was treated with a foramen ovale device and second with septal occluder due to the diameter of the foramen. Both patients have remained asymptomatic during the follow-up period. Conclusions: The PFO devices are indicated for patients with a history of cerebrovascular accidents. (Arch Cardiol Mex 2005; 75: 306-309)

REFERENCES

1. Lechat P, Mas JL, Lascault G: Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318: 1148-52.

2. Webster MWI, Smith HJ, Sharpe DN: Patent foramen ovale in young stroke patients. Lancet 1988; 2: 11-12.

3. Dearani JA, Ugurlu BS, Danielson GK, Gordon K, Richard CD, Chistopher GA, et al: Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999; 100 (Supplement 2): 171.

4. Walsh KP, Wilmshurst PT, Morrison WL: Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers. Heart 1999; 81: 257-261.

5. Morandi E, Anziola GP, Angeli S, Melzi G, Honorato E: Transcatheter closure of patent foramen ovale: A new migraine treatment? J Interven Cardiol 2003; 16: 39-42.

6. Hung J, Landzberg MJ, Jenkings KJ: Transcatheter closure of patent foramen ovale for paradoxical emboli: incidence of recurrent neurologic events at intermediate term follow up. J Am Coll Cardiol 2000; 35: 1311-1316.

7. Bridges ND, Hellenbrand W, Latson L: Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992; 86: 1902-1908.

8. Han Y, Gu X, Titus JL: New self-expanding patent foramen ovale occlusion device. Cathet Cardiovasc Diag 1999; 47: 370-6.

9. Audrey C, Marshall JY, Lock JE: Structural and compliant anatomy of the patent foramen ovale in patients undergoing transcatheter closure. Am Heart J 2000; 140: 303-7.

10. Rome JJ, Keane JF, Perry SB: Double-umbrella closure of atrial defects: initial clinical applications. Circulation 1990; 82: 751-8.

11. Ende DJ, Chopra PS, Rao PS: Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxical embolism. Am J Cardiol 1996; 78: 233-6.

12. Sievert H, Babic U, Hausdorf G: Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (a multi-institutional European trial). Am J Cardiol 1998; 82: 1405-13.

13. Chan KC, Goodman MJ, Walsh K: Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart 1999; 82: 300-6.